2021 American Transplant Congress
Clinical Outcomes and Management of Covid-19 Patients Among Kidney Transplant Recipients: A Systematic Review
*Purpose: We aim to systematically review published literature and synthesize the evidence available on therapeutic interventions and clinical outcomes used in the management of COVID-19…2021 American Transplant Congress
Covid-19-related Knowledge, Health Behaviors and Attitudes Towards Telemedicine and Emergency Visits in a Population of Kidney Transplant (KTx) Recipients
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: We explored knowledge about COVID-19 and attitudes towards emergency care and telemedicine visits in a population of inner-city KTx pts.*Methods: A telephone survey was…2021 American Transplant Congress
Evaluation of Fungal Prophylaxis Post-Lung Transplantation
1Temple University Hospital, Philadelphia, PA, 2Temple School of Pharmacy, Philadelphia, PA
*Purpose: Fungal infections are responsible for approximately 15-35% of all infections in lung transplant recipients; 80% of which are due to aspergillus or candida. At…2021 American Transplant Congress
Longitudinal Antibody Response and Viral Loads in Covid-infected Organ Transplant Recipients
*Purpose: The full spectrum of COVID-19 disease and the impact of disease severity on antibody response and viral shedding dynamics in transplant patients is unclear.…2021 American Transplant Congress
The Metagenomic Landscape of Renal Transplant
1Emory University, Atlanta, GA, 2Surgery, Emory University, Atlanta, GA
*Purpose: The selective targeting of T cells in transplant immunosuppression medications leads to a high rate of viral infections. Different immunosuppression regimens have been shown…2021 American Transplant Congress
Immunosuppression is Not Associated with High-risk Immunologic Parameters in Transplant Recipients with the Sars-cov2 Virus
Medicine/Surgery, Columbia University Medical Center, New York, NY
*Purpose: The factors associated with severe COVID-19 disease in transplant patients are poorly understood. Despite concern that patients with weakened immune responses have increased risk…2021 American Transplant Congress
An Evaluation of Pjp Prophylaxis and Anemia Among Renal Transplant Recipients
NewYork-Presbyterian Hospital, New York, NY
*Purpose: Dapone and atovaquone are therapeutic options for PJP prophylaxis in renal transplant recipients. The objective of this study was to evaluate the incidence of…2021 American Transplant Congress
Covid-19 Reinfection in a Kidney Transplant Patient
Nephrology, Yale School of Medicine, New Haven, CT
*Purpose: Several cases have demonstrated positive SARS-CoV-2 PCR testing in patients who were initially shown to have cleared the infection. These reinfections may represent new…2021 American Transplant Congress
Covid 19 Re-infection versus Re-activation in Two Renal Transplant Patients
Montefiore Medical Center, New York, NY
*Purpose: Rare cases of potential COVID 19 re-infection have been reported throughout the world.*Methods: We describe two renal transplant recipients with possible SARS-COV-2 re-infection.*Results: Patient…2021 American Transplant Congress
Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection
Pharmacy, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Rabbit antithymocyte globulin (rATG) is FDA approved for kidney transplant induction therapy and treatment of T-cell mediated rejection (TCMR). While prior studies comparing dosing…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 84
- Next Page »